UiPath Q2 Results Beat Street View, But Shares Down 7%

Shares of UiPath Inc. (PATH) slipped over 7% in extended trading session Tuesday despite the robotic process automation solutions provider's second-quarter results beating Wall Street view.

The company reported second-quarter net loss of $100.0 million or $0.19 per share, compared to last year's profit of $5.0 million or break even per share.

On an adjusted basis, UiPath reported earnings of $0.01 per share, down from $0.03 per share last year. Analysts polled by Thomson Reuters expected a loss of $0.05 per share for the quarter. Analysts' estimates typically exclude one-time items.

Revenues for the second quarter rose 40% to $195.5 million from $139.4 million last year. Analysts had a consensus revenue estimate of $184.34 million for the quarter.

"We continued our very strong momentum in the second quarter of fiscal year 2022 with ARR growing 60 percent year-over-year to $726.5 million. Our results were driven by both new customer additions, ending the quarter with more than 9,100 customers, as well as robust expansion with existing customers, reflected in our best-in-class dollar-based net retention rate of 144 percent," said CEO Daniel Dines.

Looking forward the third quarter, UiPath expects annualized renewal run rate or ARR of $796 million and $798 million and revenues of $207 million and $209 million. Analysts currently estimate revenues of $206.17 million for the quarter.

For the full year 2022, UiPath expects ARR of $876 million and $881 million.

ARR is a metric used to predict the financial performance of SaaS company over the coming year based on past earnings data.

PATH closed Tuesday's trading at $62.46, down $0.91 or 1.44%, on the Nasdaq. The stock further slipped $4.71 or 7.54% in the after-hours trading.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals. United Airlines operated Thursday the first ever passenger flight using 100% Sustainable Aviation Fuel or SAF as part of its efforts to combat climate change. The airline flew the green flight from Chicago's O'Hare International Airport or ORD to Washington, D.C.'s Reagan National Airport or DCA with more than 100 passengers.
Follow RTT